BFG
IDXX icon

Bleakley Financial Group’s Idexx Laboratories IDXX Stock Holding History

Bleakley Financial Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,470
Closed -$1.02M – 726
2024
Q4 		$1.02M Sell
2,470
-391
-14% -$172K 0.03% 403
2024
Q3 		$1.45M Buy
2,861
+39
+1% +$18.9K 0.04% 319
2024
Q2 		$1.37M Buy
2,822
+49
+2% +$24.6K 0.04% 345
2024
Q1 		$1.5M Sell
2,773
-30
-1% -$16.4K 0.04% 345
2023
Q4 		$1.56M Sell
2,803
-1
-0% -$469 0.05% 321
2023
Q3 		$1.23M Sell
2,804
-183
-6% -$91.3K 0.04% 348
2023
Q2 		$1.5M Sell
2,987
-8
-0.3% -$3.83K 0.05% 322
2023
Q1 		$1.5M Sell
2,995
-228
-7% -$109K 0.05% 315
2022
Q4 		$1.31M Buy
+3,223
New +$1.25M 0.05% 336

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Bleakley Financial Group's IDXX Position: Q1 2025 in Review

Bleakley Financial Group sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 2,470 shares — an estimated $1.02M sold.

Bleakley Financial Group first reported a position in IDXX in Q4 2022 and held it in 9 quarters. The position peaked at $1.56M in Q4 2023. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Bleakley Financial Group reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • Bleakley Financial Group sold 2,470 Idexx Laboratories shares in Q1 2025, an estimated $1.02M.
  • Bleakley Financial Group first reported a position in Idexx Laboratories in Q4 2022 and held it in 9 quarters.
  • Bleakley Financial Group's Idexx Laboratories position peaked at $1.56M in Q4 2023.
  • 1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Bleakley Financial Group's 13F filing for Q1 2025, filed 1 May 2025.